Kevin Manocha, MD
Clinical Cardiac Electrophysiology · Raleigh, NCNPI 1518304625
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (51.9%), food and beverage and grants — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Biotronik Inc. at 51.3% of the total. Among clinical cardiac electrophysiology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 771 payments — averaging $189.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$75K
- Boston Scientific$20K
- Medtronic$18K
- Abbott$11K
- Atricure, Inc.$6K
- Sanofi-aventis U.S. LLC$4K
- plus $11K from 25 others
What the payments were for
- Consulting fees$3,7563%
- Speaking & faculty fees$7,6455%
- Grants$16,92712%
- Travel & lodging$75,77552%
- Food & beverage$41,27828%
- Education$6190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 309 | $74,967 |
| Boston Scientific | 122 | $20,328 |
| Medtronic(2 entities) | 86 | $17,702 |
| Abbott | 67 | $11,132 |
| Atricure, Inc. | 33 | $6,480 |
| Sanofi-aventis U.S. LLC | 5 | $4,088 |
| Philips North America LLC | 12 | $2,332 |
| Biosense Webster, Inc. | 30 | $1,917 |
| Altathera Pharmaceuticals LLC | 2 | $1,774 |
| Medical Device Business Services, Inc. | 12 | $1,643 |
| Impulse Dynamics (USA) Inc. | 7 | $851 |
| Amgen | 16 | $446 |
| Johnson & Johnson(2 entities) | 5 | $336 |
| Cardiva Medical, Inc. | 9 | $290 |
| AstraZeneca | 10 | $278 |
| Novartis | 11 | $226 |
| Chiesi USA, Inc. | 3 | $166 |
| Stryker | 1 | $149 |
| ZOLL Respicardia, Inc. | 1 | $130 |
| Abiomed | 1 | $125 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $123 |
| Terumo Medical Corporation | 2 | $116 |
| Volta Medical Inc | 1 | $108 |
| Pfizer | 2 | $67 |
| Boehringer Ingelheim | 2 | $57 |
| Kestra Medical Technology Services, Inc. | 2 | $42 |
| Elutia, Inc. | 2 | $42 |
| Irhythm Technologies, Inc. | 1 | $28 |
| Scpharmaceuticals Inc. | 1 | $24 |
| Baxter Healthcare | 1 | $20 |
| Siemens Medical Solutions USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BioMonitor$11,085
- Solia$10,512
- Acticor 7 VR-T DX$8,912
- Edora 8 DR-T$6,046
- Rivacor 7 DR-T$5,808
- Edora$4,728
- Acticor$4,728
- Rivacor$4,728
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$4,586
- GENERAL - THERAPIES$4,270
- GENERAL BRADY$3,750
- Selectra$2,769
- AMVIA EDGE$2,182
- Ensite Cardiac Mapping System$1,926
- Sotalol Hydrochloride$1,750
- AVEIR$1,524
- OPTIMIZER$1,470
- Carto 3 System$1,343
- SYNERGY ABLATION SYSTEM$1,292
- IGT Devices Und$1,242
How this compares
$145,999 in reported general payments places this provider in the 90th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.
See all clinical cardiac electrophysiology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 240 | $235,464 |
| XareltoRivaroxaban | 28 | $37,912 |
| MultaqDronedarone Hcl | 15 | $21,993 |
| Metoprolol Succinate | 236 | $2,711 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 14 | $2,574 |
| Diltiazem 12hr ErDiltiazem Hcl | 11 | $1,768 |
| Flecainide Acetate | 61 | $1,715 |
| Amiodarone Hcl | 52 | $858 |
| SotalolSotalol Hcl | 36 | $645 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 25 | $607 |
| Ranolazine ErRanolazine | 17 | $554 |
| Furosemide | 50 | $266 |
| Carvedilol | 24 | $150 |
| Pantoprazole Sodium | 16 | $73 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $67 | $235,464240 claims |
| Johnson & JohnsonXarelto | $336 | $37,91228 claims |
| Sanofi-aventis U.S. LLCMultaq | $4,088 | $21,99315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.
Other clinical cardiac electrophysiology in Raleigh
- Marc SilverRaleigh$113K
- Sidharth ShahRaleigh$55K
- Joseph BumgarnerRaleigh$53K
- Ashish PatelRaleigh$15K
- Michael ManogueAsheville$230K
- Daniel FriedmanDurham$196K
- James AllredGreensboro$184K
- John RhynerAsheville$168K
- Gregory HarrisGreenville$164K
- John CatanzaroGreenville$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.